Pasi Aronen
About
Pasi Aronen is a scholar working on Surgery, Epidemiology and Oncology.
According to data from OpenAlex, Pasi Aronen has authored 27 papers receiving a total of 614 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Surgery, 5 papers in Epidemiology and 4 papers in Oncology. Recurrent topics in Pasi Aronen's work include Shoulder Injury and Treatment (4 papers), Virus-based gene therapy research (3 papers) and CAR-T cell therapy research (3 papers). Pasi Aronen is often cited by papers focused on Shoulder Injury and Treatment (4 papers), Virus-based gene therapy research (3 papers) and CAR-T cell therapy research (3 papers). Pasi Aronen collaborates with scholars based in Finland, Sweden and Canada. Pasi Aronen's co-authors include Harri Sintonen, Antti Malmivaara, Yrjö T. Konttinen, Esa Läärä, Simo Taimela, Maunu Nissinen, I Arnala, Matti Lehtinen, Saara Ketola and Hanna Vaahtoranta‐Lehtonen and has published in prestigious journals such as Journal of Bone and Joint Surgery, Annals of Oncology and Lara D. Veeken.
In The Last Decade
Pasi Aronen
26 papers receiving 594 citations
Peers
Pasi Aronen
Muhammed Şahin Türkiye
Bharat Kumar United States
Juan C. Rueda Colombia
Aiyuan Xie United States
Ashvini K. Reddy United States
Eric D. Newman United States
R. Peter Manes United States
Christina Samel Germany
Heinrike Schmeling Canada
Ihab Ahmed Egypt
Citations per year, relative to Pasi Aronen Pasi Aronen (= 1×)
peers
Muhammed Şahin
Countries citing papers authored by Pasi Aronen
Since
Specialization
Citations
This map shows the geographic impact of Pasi Aronen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pasi Aronen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pasi Aronen more than expected).
Fields of papers citing papers by Pasi Aronen
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Pasi Aronen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pasi Aronen. The network helps show where Pasi Aronen may publish in the future.
Co-authorship network of co-authors of Pasi Aronen
This figure shows the co-authorship network connecting the top 25 collaborators of Pasi Aronen. A scholar is included among the top collaborators of Pasi Aronen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pasi Aronen. Pasi Aronen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Lähdeoja, Tuomas, Niklas Pakkasjärvi, Pasi Aronen, et al.. (2023). Outcomes at a Mean of 13 Years After Proximal Humeral Fracture During Adolescence. Journal of Bone and Joint Surgery. 105(11). 839–848.
2.
Aronen, Pasi, Martti Färkkilâ, Leena Kylänpää, et al.. (2021). Use of thiopurines is not a risk factor for post-ERC pancreatitis in patients with primary sclerosing cholangitis. Digestive and Liver Disease. 53(8). 1020–1027.
3.
Paavola, Mika, et al.. (2021). Return to work after subacromial decompression, diagnostic arthroscopy, or exercise therapy for shoulder impingement: a randomised, placebo-surgery controlled FIMPACT clinical trial with five-year follow-up. BMC Musculoskeletal Disorders. 22(1). 889–889.
4.
Lindström, Veronica, et al.. (2021). Exploring safety culture in the Finnish ambulance service with Emergency Medical Services Safety Attitudes Questionnaire. Scandinavian Journal of Trauma Resuscitation and Emergency Medicine. 29(1). 148–148.
5.
Kanto, Kari, Tuomas Lähdeoja, Mika Paavola, et al.. (2021). Minimal important difference and patient acceptable symptom state for pain, Constant-Murley score and Simple Shoulder Test in patients with subacromial pain syndrome. BMC Medical Research Methodology. 21(1). 45–45.
6.
Zafar, Sadia, Dafne C.A. Quixabeira, João M. Santos, et al.. (2020). Oncolytic Adenovirus Type 3 Coding for CD40L Facilitates Dendritic Cell Therapy of Prostate Cancer in Humanized Mice and Patient Samples. Human Gene Therapy. 32(3-4). 192–202.
7.
Aro, Katri, Anna‐Maria Koivusalo, Tommy Wilkman, et al.. (2020). Perioperative Dexamethasone Is Associated With Higher Short-Term Mortality in Reconstructive Head and Neck Cancer Surgery. Journal of Oral and Maxillofacial Surgery. 78(10). 1835–1845.
8.
Zafar, Sadia, Dafne C.A. Quixabeira, Víctor Cervera-Carrascón, et al.. (2020). Ad5/3 is able to avoid neutralization by binding to erythrocytes and lymphocytes. Cancer Gene Therapy. 28(5). 442–454.
9.
Lönnrot, Kimmo, Simo Taimela, Pasi Aronen, et al.. (2019). Finnish Trial on Practices of Anterior Cervical Decompression and Fusion (FACADE): a protocol for a prospective randomised non-inferiority trial comparing outpatient versus inpatient care. BMJ Open. 9(11). e032575–e032575.
10.
Aaltonen, Kalle, Pasi Aronen, Tuulikki Sokka, et al.. (2016). Cost-effectiveness of biologic compared with conventional synthetic disease-modifying anti-rheumatic drugs in patients with rheumatoid arthritis: a Register study. Lara D. Veeken. 55(10). 1803–1811.
11.
Aaltonen, Kalle, Liisa Virkki, Tuulikki Sokka, et al.. (2015). Rates of Serious Infections and Malignancies Among Patients with Rheumatoid Arthritis Receiving Either Tumor Necrosis Factor Inhibitor or Rituximab Therapy. The Journal of Rheumatology. 42(3). 372–378.
12.
Sintonen, Harri, et al.. (2010). Economic evaluation of multidisciplinary rehabilitation after primary total knee arthroplasty based on a randomized controlled trial. Arthritis Care & Research. 63(3). 335–341.
13.
Taimela, Simo, Pasi Aronen, Antti Malmivaara, et al.. (2009). Effectiveness of a Targeted Occupational Health Intervention in Workers with High Risk of Sickness Absence: Baseline Characteristics and Adherence as Effect Modifying Factors in a Randomized Controlled Trial. Journal of Occupational Rehabilitation. 20(1). 14–20.
14.
Seppä, L., Satu Lahti, Ahti Niinimaa, et al.. (2009). Cost‐effectiveness of an experimental caries‐control regimen in a 3.4‐yr randomized clinical trial among 11–12‐yr‐old Finnish schoolchildren. European Journal Of Oral Sciences. 117(6). 728–733.
15.
Ketola, Saara, Matti Lehtinen, I Arnala, et al.. (2009). Does arthroscopic acromioplasty provide any additional value in the treatment of shoulder impingement syndrome?. Journal of Bone and Joint Surgery - British Volume. 91-B(10). 1326–1334.
16.
Taimela, Simo, Pasi Aronen, Harri Sintonen, et al.. (2007). An occupational health intervention programme for workers at high risk for sickness absence. Cost effectiveness analysis based on a randomised controlled trial. Occupational and Environmental Medicine. 65(4). 242–248.
17.
Kuukasjärvi, Pekka, Pirjo Räsänen, Antti Malmivaara, Pasi Aronen, & Harri Sintonen. (2007). Economic evaluation of drug-eluting stents: A systematic literature review and model-based cost–utility analysis. International Journal of Technology Assessment in Health Care. 23(4). 473–479.
18.
Vaahtoranta‐Lehtonen, Hanna, Anja Tuulonen, Pasi Aronen, et al.. (2007). Cost effectiveness and cost utility of an organized screening programme for glaucoma. Acta Ophthalmologica Scandinavica. 85(5). 508–518.
19.
Jula, Antti, Pasi Aronen, Minna Kaila, et al.. (2007). Cost-effectiveness analysis of guidelines for antihypertensive care in Finland. BMC Health Services Research. 7(1). 172–172.
20.
Kellokumpu‐Lehtinen, Pirkko, Jonas Bergh, Eeva Salminen, et al.. (2006). Cost-effectiveness of intensive adjuvant chemotherapy for high-risk breast cancer: Is tailored and dose-escalated chemotherapy with growth factor support (GFS) more costly and less effective than marrow-supported high-dose chemotherapy – results from a randomized study. Acta Oncologica. 46(2). 146–152.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Muhammed Şahin Breakdown of academic impact, for papers by Bharat Kumar Breakdown of academic impact, for papers by Juan C. Rueda Breakdown of academic impact, for papers by Aiyuan Xie Breakdown of academic impact, for papers by Ashvini K. Reddy Breakdown of academic impact, for papers by Eric D. Newman Breakdown of academic impact, for papers by R. Peter Manes Breakdown of academic impact, for papers by Christina Samel Breakdown of academic impact, for papers by Heinrike Schmeling Breakdown of academic impact, for papers by Ihab Ahmed